Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

被引:457
作者
Kimura, H
Morita, M
Yabuta, Y
Kuzushima, K
Kato, K
Kojima, S
Matsuyama, T
Morishima, T
机构
[1] Nagoya Univ, Sch Med, Dept Pediat, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Aichi Canc Ctr, Res Inst, Lab Viral Oncol, Nagoya, Aichi 464, Japan
[3] Nagoya First Hosp, Japanese Red Cross, Childrens Med Ctr, Div Hematol Oncol, Nagoya, Aichi, Japan
关键词
D O I
10.1128/JCM.37.1.132-136.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To measure the virus load in patients with symptomatic Epstein-Barr virus (EBV) infections, we used a realtime PCR assay to quantify the amount of EBV DNA in blood. The real-time PCR assay could detect from 2 to over 10(7) copies of EBV DNA with a wide linear range. We estimated the virus load in peripheral blood mononuclear cells (PBMNC) from patients,vith symptomatic EBV infections. The mean EBV-DNA copy number in the PBMNC was 10(3.7) copies/mu g of DNA in patients with EBV-related lymphoproliferative disorders, 10(4.1) copies/mu g of DNA in patients with chronic active EBV infections, and 10(2.2) copies/mu g of DNA in patients,vith infectious mononucleosis. These numbers were significantly larger than those in either posttransplant patients or immunocompetent control patients without EBV-related diseases. In a patient with infectious mononucleosis, the virus load decreased as the symptoms resolved. The copy number of EBV DNA in PBMNC from symptomatic EBV infections was correlated with the EBV-positive cell number determined by the in situ hybridization assay (r = 0.842; P < 0.0001). These results indicate that the real-time PCR assay is useful for diagnosing symptomatic EBV infection and for monitoring the virus load.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 40 条
[1]   DNA-SEQUENCE AND EXPRESSION OF THE B95-8 EPSTEIN-BARR VIRUS GENOME [J].
BAER, R ;
BANKIER, AT ;
BIGGIN, MD ;
DEININGER, PL ;
FARRELL, PJ ;
GIBSON, TJ ;
HATFULL, G ;
HUDSON, GS ;
SATCHWELL, SC ;
SEGUIN, C ;
TUFFNELL, PS ;
BARRELL, BG .
NATURE, 1984, 310 (5974) :207-211
[2]  
Bai X, 1997, CLIN CHEM, V43, P1843
[3]  
BEUTLER E, 1990, BIOTECHNIQUES, V9, P166
[4]   DETECTION OF CELL-FREE EPSTEIN-BARR-VIRUS DNA IN SERUM DURING ACUTE INFECTIOUS-MONONUCLEOSIS [J].
GAN, YJ ;
SULLIVAN, JL ;
SIXBEY, JW .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :436-439
[5]   A novel method for real time quantitative RT PCR [J].
Gibson, UEM ;
Heid, CA ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :995-1001
[6]  
GRATAMA JW, 1994, BONE MARROW TRANSPL, P429
[7]   EPSTEIN-BARR VIRUS-INDUCED B-CELL LYMPHOMA AFTER RENAL-TRANSPLANTATION - ACYCLOVIR THERAPY AND TRANSITION FROM POLYCLONAL TO MONOCLONAL B-CELL PROLIFERATION [J].
HANTO, DW ;
FRIZZERA, G ;
GAJLPECZALSKA, KJ ;
SAKAMOTO, K ;
PURTILO, DT ;
BALFOUR, HH ;
SIMMONS, RL ;
NAJARIAN, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (15) :913-918
[8]   Real time quantitative PCR [J].
Heid, CA ;
Stevens, J ;
Livak, KJ ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :986-994
[9]   Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes [J].
Heslop, HE ;
Ng, CYC ;
Li, CF ;
Smith, CA ;
Loftin, SK ;
Krance, RA ;
Brenner, MK ;
Rooney, CM .
NATURE MEDICINE, 1996, 2 (05) :551-555
[10]   DETECTION OF EPSTEIN-BARR-VIRUS TRANSCRIPTS IN CHEMICALLY OR IMMUNOLOGICALLY-ACTIVATED CELLS AND IN A NULL CELL-LINE (HLN-STL-C) BY IN-SITU HYBRIDIZATION WITH ALKALINE PHOSPHATASE-LINKED OLIGONUCLEOTIDE PROBES [J].
HIRONAKA, T ;
NAGASAKI, M ;
MORIKAWA, S ;
HIRAI, K .
JOURNAL OF VIROLOGICAL METHODS, 1993, 44 (2-3) :141-154